🇺🇸 Patch, Nicotine in United States
33 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 33
Most-reported reactions
- Weight Increased — 5 reports (15.15%)
- Insomnia — 4 reports (12.12%)
- Anxiety — 3 reports (9.09%)
- Blood Glucose Increased — 3 reports (9.09%)
- Condition Aggravated — 3 reports (9.09%)
- Depression — 3 reports (9.09%)
- Dizziness — 3 reports (9.09%)
- Drug Ineffective — 3 reports (9.09%)
- Dyspnoea — 3 reports (9.09%)
- Hypertension — 3 reports (9.09%)
Other Addiction Medicine / Smoking Cessation approved in United States
Frequently asked questions
Is Patch, Nicotine approved in United States?
Patch, Nicotine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Patch, Nicotine in United States?
Assistance Publique - Hôpitaux de Paris is the originator. The local marketing authorisation holder may differ — check the official source linked above.